Recursion Pharmaceuticals Inc vs VICI Properties Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while VICI Properties Inc trades at $26.66 (market cap $29.55B). The key difference: VICI Properties Inc is far larger — about 19.3× Recursion Pharmaceuticals Inc's market cap, and VICI Properties Inc pays a 6.71% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | VICI | |
|---|---|---|
Market Cap | $1.53B | $29.55B |
Sector | Health | Real Estate |
52-Week High | $6.79 | $33.93 |
52-Week Low | $2.84 | $25.94 |
Enterprise Value | $946.50M | $46.77B |
Dividend Yield | — | 6.71% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →